Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents | Next Article »
Stroke. 2006;37:1144-1145
Published online before print April 6, 2006, doi: 10.1161/01.STR.0000219643.43966.0d
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/5/1144    most recent
01.STR.0000219643.43966.0dv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bennett, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bennett, D. A.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Stroke
Related Collections
Right arrow Health policy and outcome research
Right arrow Epidemiology
Right arrowRelated Article

(Stroke. 2006;37:1144.)
© 2006 American Heart Association, Inc.

Editorials

Secular Trends in Stroke Incidence and Survival, and the Occurrence of Dementia

David A. Bennett, MD

From the Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL.

Correspondence to David A. Bennett, Rush Alzheimer’s Disease Center, Rush University Medical Center, 600 S Paulina, Suite 1028, Chicago, IL, 60612. E-mail dbennett{at}rush.edu


Key Words: dementia • epidemiology • stroke

See related article, pages 1155–1159

The 20th century witnessed marked improvements in public health and drastic reductions in mortality from common diseases of early- and midlife leading to a large and growing segment of the population over the age of 65.1 These demographic trends are expected to continue in the coming decades.1 As a result, demographers are forecasting an increase in the number of persons with common chronic conditions of aging. Among the most common, most feared, and most expensive conditions for individuals, families, and society is progressive dementia. Recent data suggest that the number of persons with dementia in the world will increase markedly over the coming decades.2,3 Accurate forecasts of the occurrence of dementia and other age-related conditions in the future are essential for proper public health planning. However, such forecasts rely on a number of assumptions in addition to census projections regarding fertility, mortality, and immigration. For example, after Alzheimer disease, stroke is generally considered to be the second most common cause of dementia.4,5 Recent data suggest that the lifetime risk of both stroke and dementia are very high.6 In addition, health care utilization costs of dementia related to stroke appears to exceed that of Alzheimer disease on a per patient basis.7,8 These data suggest that recent trends in the incidence of and survival from stroke could have important implications for future estimates of the occurrence of dementia and the costs associated with dementia care. Unfortunately, information on the association of trends in stroke incidence and survival with the occurrence of dementia is limited.

In this issue of Stroke, Ukrainsteva et al linked data from the National Long-Term Care Survey (NLTCS) to data from Medicare Part A to compare stroke incidence and survival, and rates of dementia from 1984 to 1990 to 1991 to 2001 for persons over the age of 65 in the United States.9 The NLTCS is a nationally representative sample of >40 000 Medicare enrollees in the United States. Medicare Part A is the insurance program that covers inpatient care and a variety of posthospitalization skilled care. Diagnoses of stroke, dementia, and dementia subtypes were based on ICD-9-CM diagnostic codes. Dementia diagnoses were separated into 3 all inclusive and mutually exclusive hierarchical categories: Alzheimer disease, dementia related to cerebrovascular disease, and other dementias. Persons with dementia before stroke were excluded from the analyses. The authors found a slight increase in age-adjusted rates of stroke that approached significance. Stroke survival increased markedly, with most of the increase apparent in the first year after stroke consistent with lower stroke case fatality. The authors also found a substantial increase in the age adjusted rates of dementia, mostly attributable to an increase in Alzheimer disease. Finally, among those with stroke, there was a nearly 4-fold increase in dementia related to cerebrovascular disease. Interestingly, there was more than a 50% increase in Alzheimer disease among those with stroke, which approached but was not significant. By contrast, among those without stroke, there was more than a 50% increase in Alzheimer disease, more than a 25% increase in dementia related to cerebrovascular disease, and a small increase in other dementias.

The study is not without limitations, most of which were acknowledged by the authors. Most importantly, cases were restricted to hospitalized patients. However, many people with dementia and some with stroke do not come to the attention of the health care system. The reason some are hospitalized and others are not is likely to vary by age and socioeconomic status. For example, rates of stroke and dementia in this study appear to decline after age 90, which is inconsistent with most epidemiologic studies, although data for this age group are sparse. Further, because of changes in reimbursement over the past 2 decades, fewer persons with uncomplicated diagnoses are hospitalized, suggesting that more severe strokes, perhaps those more likely to be associated with dementia, may be over-represented in this study. Finally, uniform diagnostic procedures were not used, which also could introduce bias. Nonetheless, the study provides unique and potentially important data regarding the relation of secular trends in stroke and the occurrence of dementia over the past 2 decades. Data such as these are essential for determining the public health burden of stroke and dementia in the future.

The data in this study suggest that an ongoing decline in case fatality from stroke may be contributing to a rise in dementia, both dementia attributable to cerebrovascular disease, and dementia resulting from Alzheimer disease. Because it is likely that survival from stroke will continue to improve in the coming years, this may portend an increase in the numbers of stroke-related dementia in the future. These changes may be compounded, to some extent, by a slight increase in stroke incidence, although trends in stroke incidence remain controversial.10–12 The rise in stroke incidence, if present, is likely to be occurring primarily among the elderly who represent those at highest risk for dementia. In the coming decades, the slight rise in stroke incidence may be exacerbated by other trends in the prevalence of vascular risk factors including obesity and diabetes among young and middle aged adults.13,14 Together, these trends may counterbalance, to some degree, the general decline in age-related disability that has been accruing over the past 2 decades.15,16

It is interesting to note that although most of the increased risk of dementia associated with stroke was coded as dementia related to cerebrovascular disease, there was also a substantial increase in Alzheimer disease diagnosis among those with stroke. This is consistent with recent data suggesting that risk factors for stroke such as high blood pressure and diabetes may be associated with risk of Alzheimer disease,17,18 and that some well known risk factors for Alzheimer disease such as apolipoprotein E allele status may also be associated with risk of cerebral infarctions.19 The mechanisms linking stroke and stroke risk factors to Alzheimer disease are complicated, and it is premature to conclude that vascular disease or vascular risk factors cause amyloid deposition and tangle formation, the pathologic hallmarks of Alzheimer disease. It is now fairly clear from both imaging and clinical-pathologic studies that subclinical cerebrovascular disease is associated with risk of dementia.20,21 Further, clinical-pathologic studies suggest that cerebral infarction may add or interact with Alzheimer disease pathology to cause dementia.22,23 Thus, it is likely that clinical and subclinical cerebrovascular disease are capable of unmasking the pathology of Alzheimer disease leading to dementia. Further research is needed to see whether there are other more direct links between cerebrovascular disease and Alzheimer disease. The data from this study suggest that now would be a good time to conduct this research.

Footnotes

The opinions in this editorial are not necessarily those of the editors or of the American Heart Association.

References

  1. He W, Sengupta M, Velkoff VS, DeBarros KA. 65+ in the United States:2005. US Census Bureau. 2005.
  2. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M; Alzheimer’s Disease International. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005; 366: 2112–2117.[CrossRef][Medline] [Order article via Infotrieve]
  3. Wimo A, Winblad B, Aguero-Torres H, von Strauss E. The magnitude of dementia occurrence in the world. Alzheimer Dis Assoc Disord. 2003; 17: 63–67.[CrossRef][Medline] [Order article via Infotrieve]
  4. Liebetrau M, Steen B, Skoog I. Stroke in 85-year-olds: prevalence, incidence, risk factors, and relation to mortality and dementia. Stroke. 2003; 34: 2617–2622.[Abstract/Free Full Text]
  5. Ivan CS, Seshadri S, Beiser A, Au R, Kase CS, Kelly-Hayes M, Wolf PA. Dementia after stroke: the Framingham Study. Stroke. 2004; 35: 1264–1268.[Abstract/Free Full Text]
  6. Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Au R, Kannel WB, Wolf PA. The lifetime risk of stroke: estimates from the Framingham Study. Stroke. 2006; 37: 345–350.[Abstract/Free Full Text]
  7. Hill J, Fillit H, Shah SN, del Valle MC, Futterman R. Patterns of healthcare utilization and costs for vascular dementia in a community-dwelling population. J Alzheimers Dis. 2005; 8: 43–50.[Medline] [Order article via Infotrieve]
  8. Sicras A, Rejas J, Arco S, Flores E, Ortega G, Esparcia A, Suarez A, Gordillo MJ. Prevalence, resource utilization and costs of vascular dementia compared to Alzheimer’s dementia in a population setting. Dement Geriatr Cogn Disord. 2005; 19: 305–315.[CrossRef][Medline] [Order article via Infotrieve]
  9. Ukraintseva S, Sloan F, Arbeev K, Yashin A. Increasing rates of dementia at a time of declining mortality from stroke. Stroke. 2006; 37: 1155–1159.[Abstract/Free Full Text]
  10. Brown RD, Whisnant JP, Sicks JD, O’Fallon WM, Wiebers DO. Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke. 1996; 27: 373–380.[Medline] [Order article via Infotrieve]
  11. May DS, Kittner SJ. Use of Medicare claims data to estimate national trends in stroke incidence, 1985–1991. Stroke. 1994; 25: 2343–2347.[Abstract]
  12. Feigin VL, Lawes CM, Bennett DA, Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. 2003; 2: 43–53.[CrossRef][Medline] [Order article via Infotrieve]
  13. Leveille SG, Wee CC, Iezzoni LI. Trends in obesity and arthritis among baby boomers and their predecessors, 1971–2002. Am J Public Health. 2005; 95: 1607–1613.[Abstract/Free Full Text]
  14. Steinbrook R. Facing the diabetes epidemic–mandatory reporting of glycosylated hemoglobin values in New York City. N Engl J Med. 2006; 354: 545–548.[Free Full Text]
  15. Wolf DA, Hunt K, Knickman J. Perspectives on the recent decline in disability at older ages. Milbank Q. 2005; 83: 365–395.[CrossRef][Medline] [Order article via Infotrieve]
  16. Crimmins EM. Trends in the health of the elderly. Annu Rev Public Health. 2004; 25: 79–98.[CrossRef][Medline] [Order article via Infotrieve]
  17. Freitag MH, Peila R, Masaki K, Petrovitch H, Ross GW, White LR, Launer LJ. Midlife pulse pressure and incidence of dementia: the Honolulu-Asia Aging Study. Stroke. 2006; 37: 33–37.[Abstract/Free Full Text]
  18. Arvanitakis Z, Bienias JL, Wilson RS, Evans DA, Bennett DA. Diabetes and risk of Alzheimer’s disease and decline in cognitive function. Arch Neurol. 2004; 61: 661–666.[Abstract/Free Full Text]
  19. Schneider JA, Bienias JL, Wilson RS, Berry-Kravis E, Evans DA, Bennett DA. Relation of the apolipoprotein E {epsilon}4 allele to cerebral infarction in older persons. Stroke. 2005; 36: 954–959.[Abstract/Free Full Text]
  20. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003; 348: 1215–1222.[Abstract/Free Full Text]
  21. Bennett DA, Schneider JA, Bienias JL, Evans DA, Wilson RS. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology. 2005; 64: 834–841.[Abstract/Free Full Text]
  22. Neuropathology Group. Medical Research Council Cognitive Function and Aging Study. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet. 2001; 357: 169–175.[CrossRef][Medline] [Order article via Infotrieve]
  23. Schneider JA, Wilson RS, Bienias JL, Evans DA, Bennett DA. Cerebral infarctions and the likelihood of dementia from Alzheimer’s disease pathology. Neurology. 2004; 62: 1148–1155.[Abstract/Free Full Text]

Related Article:

Increasing Rates of Dementia at Time of Declining Mortality From Stroke
Svetlana Ukraintseva, Frank Sloan, Konstantin Arbeev, and Anatoly Yashin
Stroke 2006 37: 1155-1159. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 NeurologyHome page
R. D. Monk and D. A. Bennett
Reno-cerebrovascular disease? The incognito kidney in cognition and stroke.
Neurology, July 25, 2006; 67(2): 196 - 198.
[Full Text] [PDF]

This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/5/1144    most recent
01.STR.0000219643.43966.0dv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bennett, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bennett, D. A.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Stroke
Related Collections
Right arrow Health policy and outcome research
Right arrow Epidemiology
Right arrowRelated Article

Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.